Targeted radiopharmaceuticals
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 22, 2025
Completion: Jun 30, 2032
Loading map...